VI
CNST

Versor Investments’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Versor Investments’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,588,845
Closed -$53.7M – 601
2021
Q2 		$53.7M Buy
+1,588,845
New +$40.5M 1.89% 28

Versor Investments's CNST Position: Q3 2021 in Review

Versor Investments sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 1,588,845 shares — an estimated $53.7M sold.

Versor Investments first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $53.7M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Versor Investments reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Versor Investments sold 1,588,845 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $53.7M.
  • Versor Investments first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Versor Investments's Constellation Pharmaceuticals, Inc. position peaked at $53.7M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Versor Investments's 13F filing for Q3 2021, filed 4 Nov 2021.